MGC Pharmaceuticals
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - Industrial WAMGC Pharmaceuticals (ASX: MXC) is EU based specialist medical and cosmetic cannabis company with many years of technical and commercial experience in the medical cannabis industry. The Company’s founders were key figures in the Israeli medical cannabis industry and the core business strategy is to develop and supply high quality non-psychoactive Cannabinoid resin extract (“CBD”) to the growing European cosmetics and medical markets.
The Company listed on the ASX in December 2015, following a reverse takeover of Erin Resources.
Contact Details
1202 Hay Street, WEST PERTH WA 6005
08 6382 3390
Lists and Charts
Public Companies - Industrial WA list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Collapse All Lists and Charts
Article Timeline
Company Activity
| NEWS: Tagged in MGC Pharma secures $33m in sales | 27 Aug 2021 |
| ECM DEAL: New deal has been added | 20 Jul 2021 |
| NEWS: Tagged in Board Moves June 15, 2021 | 15 Jun 2021 |
| NEWS: Tagged in Board Moves June 9, 2021 | 09 Jun 2021 |
| NEW ROLE: David Lim, Company Secretary | 09 Jun 2021 |
| M&A DEAL: New deal has been added | 10 May 2021 |
| NEWS: Tagged in MGC Pharma to acquire Israeli business | 22 Apr 2021 |
| NEW ROLE: Daniel Kendall, Chief Financial Officer | 09 Apr 2021 |
| NEW ROLE: Nadine Barry, Corporate Secretary | 09 Apr 2021 |
